Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 49,003 | 45,870 | 54,876 | 59,318 | 62,524 |
| Cost of Goods | 34,007 | 33,362 | 35,246 | 39,038 | 35,035 |
| Gross Profit | 14,996 | 12,508 | 19,646 | 20,280 | 27,489 |
| Operating Expenses | 16,175 | 14,839 | 16,952 | 20,092 | 15,542 |
| Operating Income | -1,172 | -1,969 | 2,924 | 226 | 11,982 |
| Interest Expense | 476 | 180 | 221 | 195 | 237 |
| Other Income | -228 | -322 | 79 | 304 | 174 |
| Pre-tax Income | -1,876 | -2,471 | 2,782 | 335 | 11,919 |
| Income Tax | -696 | -852 | 953 | 494 | 4,109 |
| Net Income Continuous | -1,180 | -1,619 | 1,829 | -159 | 7,810 |
| Net Income | $-1,180 | $-1,619 | $1,829 | $-159 | $7,810 |
| EPS Basic Total Ops | -0.03 | -0.04 | 0.05 | 0.00 | 0.20 |
| EPS Basic Continuous Ops | -0.03 | -0.04 | 0.05 | 0.00 | 0.20 |
| EPS Diluted Total Ops | -0.03 | -0.04 | 0.05 | 0.00 | 0.20 |
| EPS Diluted Continuous Ops | -0.03 | -0.04 | 0.05 | 0.00 | 0.20 |
| EBITDA(a) | $2,405 | $1,446 | $6,385 | $3,496 | $15,290 |